Ben Goldacre, The Guardian, Saturday 2 April 2010
This week the Association for Molecular Pathology, working with the American Civil Liberties Union, won a major victory, overturning just some of the patents owned by a company called Myriad on the BRCA1 gene for breast cancer. There are three reasons why gene patents like these are stupid: only the last one is funny. Read the rest of this entry »
Ben Goldacre, 5 September 2009, The Guardian
How do patents affect science? This week in India, US drug company Gilead lost their appeal to stop local companies making cheap copies of their Aids drug Tenofovir. They are not alone: in 2007 Novartis lost a lengthy case trying to force the Indian government into strengthening their weak patent laws. India remains the free pharmacy of the world.
Read the rest of this entry »